James Brewster Caldwell, DO | |
2433 Mahan Dr, Tallahassee, FL 32308 | |
(850) 219-8811 | |
(850) 219-8883 |
Full Name | James Brewster Caldwell |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 39 Years |
Location | 2433 Mahan Dr, Tallahassee, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639186513 | NPI | - | NPPES |
57287 | Other | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | OS7111 (Florida) | Primary |
207ND0101X | Dermatology - Mohs-micrographic Surgery | OS7111 (Florida) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dermatology Advanced Care, P.a. | 0840283099 | 2 |
Dermatology Advanced Care, P.a. | 0840283099 | 2 |
News Archive
A new study from Aarhus University has now documented that there is some truth to the claim by parents of children with ADHD that their children have more difficulty falling asleep and that they sleep more poorly than other children.
MasterCard Worldwide recently partnered with Interpol to support the global police organization's efforts to prevent websites from supplying illegal and counterfeit prescription drugs and medicines to consumers. Named "Operation Pangea III," the week-long effort covered 45 participating countries and resulted in 76 arrests to date. Additionally, 290 websites have been shut down and nearly 11,000 packages of contraband have been seized or detained.
The prevalence of self-reported mental health disabilities increased in the U.S. among non-elderly adults during the last decade, according to a study by Ramin Mojtabai, MD, PhD, of the Johns Hopkins Bloomberg School of Public Health.
As the intense debate continues over new cancer test guidelines, the Obama administration is trying to protect health care reform from the controversy's fallout.
InterMune, Inc. today announced that the company's Marketing Authorization Application (MAA), submitted on March 2 seeking approval of pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, was validated by the European Medicines Agency (EMA). Validation of the MAA by the EMA indicates that the application is complete and that the review process will begin on March 24. The proposed trade name for pirfenidone in both the United States and Europe is EsbrietĀ®.
› Verified 5 days ago
Entity Name | Dermatology Advanced Care, P.a. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376714162 PECOS PAC ID: 0840283099 Enrollment ID: O20040422001726 |
News Archive
A new study from Aarhus University has now documented that there is some truth to the claim by parents of children with ADHD that their children have more difficulty falling asleep and that they sleep more poorly than other children.
MasterCard Worldwide recently partnered with Interpol to support the global police organization's efforts to prevent websites from supplying illegal and counterfeit prescription drugs and medicines to consumers. Named "Operation Pangea III," the week-long effort covered 45 participating countries and resulted in 76 arrests to date. Additionally, 290 websites have been shut down and nearly 11,000 packages of contraband have been seized or detained.
The prevalence of self-reported mental health disabilities increased in the U.S. among non-elderly adults during the last decade, according to a study by Ramin Mojtabai, MD, PhD, of the Johns Hopkins Bloomberg School of Public Health.
As the intense debate continues over new cancer test guidelines, the Obama administration is trying to protect health care reform from the controversy's fallout.
InterMune, Inc. today announced that the company's Marketing Authorization Application (MAA), submitted on March 2 seeking approval of pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, was validated by the European Medicines Agency (EMA). Validation of the MAA by the EMA indicates that the application is complete and that the review process will begin on March 24. The proposed trade name for pirfenidone in both the United States and Europe is EsbrietĀ®.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
James Brewster Caldwell, DO 2433 Mahan Dr, Tallahassee, FL 32308 Ph: (850) 219-8811 | James Brewster Caldwell, DO 2433 Mahan Dr, Tallahassee, FL 32308 Ph: (850) 219-8811 |
News Archive
A new study from Aarhus University has now documented that there is some truth to the claim by parents of children with ADHD that their children have more difficulty falling asleep and that they sleep more poorly than other children.
MasterCard Worldwide recently partnered with Interpol to support the global police organization's efforts to prevent websites from supplying illegal and counterfeit prescription drugs and medicines to consumers. Named "Operation Pangea III," the week-long effort covered 45 participating countries and resulted in 76 arrests to date. Additionally, 290 websites have been shut down and nearly 11,000 packages of contraband have been seized or detained.
The prevalence of self-reported mental health disabilities increased in the U.S. among non-elderly adults during the last decade, according to a study by Ramin Mojtabai, MD, PhD, of the Johns Hopkins Bloomberg School of Public Health.
As the intense debate continues over new cancer test guidelines, the Obama administration is trying to protect health care reform from the controversy's fallout.
InterMune, Inc. today announced that the company's Marketing Authorization Application (MAA), submitted on March 2 seeking approval of pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, was validated by the European Medicines Agency (EMA). Validation of the MAA by the EMA indicates that the application is complete and that the review process will begin on March 24. The proposed trade name for pirfenidone in both the United States and Europe is EsbrietĀ®.
› Verified 5 days ago
David Pascoe, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1981 Capital Cir Ne, Tallahassee, FL 32308 Phone: 850-402-9444 Fax: 850-402-0188 | |
Dr. Armand B Cognetta Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1707 Riggins Rd, Tallahassee, FL 32308 Phone: 850-877-4134 Fax: 850-402-9130 | |
Dr. William Harris Green, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1707 Riggins Rd, Tallahassee, FL 32308 Phone: 850-877-4134 Fax: 850-402-9130 | |
Pamela Schofield Kennedy, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1355 Thomaswood Dr, Tallahassee, FL 32308 Phone: 850-656-4555 Fax: 850-656-4557 | |
Emily Jacox, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2626 Capital Medical Blvd, Tallahassee, FL 32308 Phone: 850-325-5000 | |
Dr. Oen-hiang Cynthia Tie, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1981 Capital Cir Ne, Tallahassee, FL 32308 Phone: 850-402-9444 Fax: 850-402-0188 | |
Michael Jay Bernhardt, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1626 Riggins Rd, Tallahassee, FL 32308 Phone: 850-877-4134 Fax: 850-402-9130 |